Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity

Breast Cancer Research and Treatment
W WulaningsihMats Lambe

Abstract

To examine factors associated with non-adherence during 5 years of endocrine treatment, including the possible influence of comorbidity burden and specific medical conditions. From all women diagnosed with stage I-III, ER-positive breast cancer in Stockholm-Gotland, Uppsala-Örebro and Northern Sweden between 2006 and 2009, we included 4645 women who had at least one dispensation of tamoxifen or aromatase inhibitors (AIs) and 5 years of follow-up without distant recurrence. A medical possession ratio of < 80% was used to define non-adherence. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) of non-adherence. During follow-up, 977 (21%) women became non-adherents. Non-adherence was associated with greater comorbidity burden assessed by Charlson comorbidity index (CCI) during follow-up (OR 1.43; 95% CI 1.08-1.88 for ≥ 2 additional scores compared to 0), pre-diagnostic HRT use (OR 1.99; 1.58-2.49), not married (OR 1.42; 1.23-1.64), high educational level (OR 1.25; 1.02-1.53 compared to lowest level), and use of symptom-relieving drugs. HER-2 positivity (OR 0.61; 0.45-0.81) and adjuvant chemotherapy (OR 0.42; 0.35-0.52) were associated with lower odds of non-adherence. Similar patterns we...Continue Reading

References

May 16, 2001·Annals of Internal Medicine·H LiuN S Wenger
Aug 22, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ivana SestakJack Cuzick
Aug 16, 2008·The Lancet Oncology·Ivana SestakUNKNOWN ATAC Trialists' Group
May 25, 2010·Breast Cancer Research and Treatment·Rebecca L Sedjo, Scott Devine
Jul 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harold J BursteinUNKNOWN American Society of Clinical Oncology
Mar 11, 2011·Mayo Clinic Proceedings·Marie T Brown, Jennifer K Bussell
Sep 7, 2011·Cancer Prevention Research·Jennifer H LinJoAnn E Manson
Jan 31, 2012·Breast Cancer Research and Treatment·Annette WigertzMats Lambe
Apr 3, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Laetitia HuiartRoch Giorgi
Jun 13, 2012·Breast Cancer Research and Treatment·Caitlin C MurphySally W Vernon
Aug 13, 2013·International Journal of Clinical Pharmacy·Lorena Rocha AyresLeonardo Régis Leira Pereira
Feb 19, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dawn L HershmanAlfred I Neugut
Jun 3, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wei HeKamila Czene
Aug 27, 2015·Journal of the National Cancer Institute·Natalia C LlarenaJacqueline S Jeruss
Nov 6, 2015·BioMed Research International·Wai Yin Lam, Paula Fresco
Apr 8, 2016·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Louise L BerylDominick L Frosch
May 3, 2016·Clinical Breast Cancer·Alejandra Hurtado-de-MendozaVanessa B Sheppard
May 25, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jacquie H ChirgwinBeat Thürlimann
Jun 7, 2016·The New England Journal of Medicine·Paul E GossWendy R Parulekar
Dec 31, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Albert J Farias, Xianglin L Du
Mar 14, 2017·Journal of Oncology Practice·Gregory S CalipNaomi Y Ko

❮ Previous
Next ❯

Citations

Jul 12, 2020·Breast Cancer Research and Treatment·Milena SantUNKNOWN European High Resolution Working Group on breast cancer
Sep 25, 2020·Breast Cancer Research and Treatment·H MännleK Münstedt
Dec 19, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lindsay J CollinTimothy L Lash
Jun 27, 2021·The Breast : Official Journal of the European Society of Mastology·Ariane Mamguem KamgaTienhan Sandrine Dabakuyo-Yonli
Aug 13, 2021·JCO Clinical Cancer Informatics·Gayathri YerrapragadaTyler J O'Neill
Sep 3, 2021·International Journal of Epidemiology·Charlotta WadstenMalin Sund

❮ Previous
Next ❯

Methods Mentioned

BETA
hormone replacement therapy

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.